Merck & Co (NY:MRK)
Press Releases about Merck & Co



WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
February 18, 2025
From Merck & Co., Inc.
Via Business Wire








Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
February 04, 2025
From Merck & Co., Inc.
Via Business Wire







Merck’s GARDASIL® Receives Expanded Approval for Males in China
January 08, 2025
From Merck & Co., Inc.
Via Business Wire

From Merck & Co., Inc.
Via Business Wire


From Merck & Co., Inc.
Via Business Wire





From Merck & Co., Inc.
Via Business Wire



Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.